FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
MLB teams navigate free agency, losing key veterans as they reshape rosters for the upcoming season.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
MLB teams navigate free agency, losing key veterans as they reshape rosters for the upcoming season.